Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4645845
Max Phase: Preclinical
Molecular Formula: C38H44F9N7O9
Molecular Weight: 571.73
Molecule Type: Unknown
Associated Items:
ID: ALA4645845
Max Phase: Preclinical
Molecular Formula: C38H44F9N7O9
Molecular Weight: 571.73
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCNC(=O)CCc1cn(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)cn1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C32H41N7O3.3C2HF3O2/c33-16-17-34-30(40)13-12-25-21-38(23-35-25)18-6-5-7-24-14-19-37(20-15-24)22-31(41)39-28-10-3-1-8-26(28)32(42)36-27-9-2-4-11-29(27)39;3*3-2(4,5)1(6)7/h1-4,8-11,21,23-24H,5-7,12-20,22,33H2,(H,34,40)(H,36,42);3*(H,6,7)
Standard InChI Key: NTUVDDUKYAUHAH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 571.73 | Molecular Weight (Monoisotopic): 571.3271 | AlogP: 3.70 | #Rotatable Bonds: 12 |
Polar Surface Area: 125.59 | Molecular Species: BASE | HBA: 7 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 9.17 | CX LogP: 1.95 | CX LogD: -0.04 |
Aromatic Rings: 3 | Heavy Atoms: 42 | QED Weighted: 0.28 | Np Likeness Score: -0.72 |
1. She X, Pegoli A, Gruber CG, Wifling D, Carpenter J, Hübner H, Chen M, Wan J, Bernhardt G, Gmeiner P, Holliday ND, Keller M.. (2020) Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M2 Receptor., 63 (8): [PMID:32233403] [10.1021/acs.jmedchem.9b02172] |
2. Gruber, Corinna G., Pegoli, Andrea, Muller, Christoph, Gratz, Lukas, She, Xueke, Keller, Max. (2020) Differently fluorescence-labelled dibenzodiazepinone-type muscarinic acetylcholine receptor ligands with high M2R affinity, 11 (7.0): [PMID:33479678] [10.1039/d0md00137f] |
Source(1):